Habibullah AKTAŞ, Serkan ÖNER, Aybala CEBECİK

A retrospective analysis on the concomitance of seborrheic dermatitis and fatty liver disease

The present study aimed to investigate the correlation between seborrheic dermatitis and fatty liver disease and to determine the impact of age, gender, and concomitant chronic diseases. The present study sample included 120 (18-65 years old) patients who were diagnosed with seborrheic dermatitis between January 2018 and December 2018 and underwent upper abdominal ultrasonography. The demographic patient data, the liver fatty tissue rate in ultrasonography reports and the presence of other concomitant diseases were analyzed in the present retrospective study. The mean age of 52 male and 68 female patients was 45.5 ± 17.2. A total of 47 (39.2%) patients had hepatic steatosis. Hepatic steatosis rate was 52% in male patients and 29.4% in female patients. The mean age of the patients with hepatic steatosis was 54.8 ± 12.7, and the mean age of the patients with normal liver findings was 38.7 ± 17.2 (p

PDF

___

Bukvić Mokos Z, Kralj M, Basta-Juzbašić A, et al. Seborrheic dermatitis: an update. Acta Dermatovenerol Croat. 2012;20:98-104.

Gupta AK, Bluhm R. J Eur Acad Dermatol Venereol. 2004;18:13-26.

Kim D, Touros A, Kim WR. Nonalcoholic Fatty Liver Disease and Metabolic Syndrome. Clin Liver Dis. 2018;22:133-140.

Khang AR, Lee HW, Yi D, et al. The fatty liver index, a simple and useful predictor of metabolic syndrome: analysis of the Korea National Health and Nutrition Examination Survey 2010-2011. Diabetes Metab Syndr Obes. 2019;12:181-190.

Imamoglu B, Hayta SB, Guner R, et al. Metabolic syndrome may be an important comorbidity in patients with seborrheic dermatitis. Arch Med Sci Atheroscler Dis. 2016;30:158-61.

Çelebi S, Ataseven H, Mengücük E, et al. Elazığ kent toplumunda nonalkolik yağlı karaciğerin epidemiyolojik özellikleri. Akademik Gastroenteroloji Dergisi. 2006;5:41-6.

Uzuncakmak TK, Akdeniz N, Karadag AS. Cutaneous manifestations of obesity and the metabolic syndrome. Clin Dermatol. 2018;36:81-8.

Hazlehurst JM, Woods C, Marjot T, et al. Non-alcoholic fatty liver disease and diabetes. Metabolism. 2016;65:1096-108.

Firneisz G. Non-alcoholic fatty liver disease and type 2 diabetes mellitus: the liver disease of our age? World J Gastroenterol. 2014;20:9072-89.

10. Stahl EC, Haschak MJ, Popovic B, et al. Macrophages in the Aging Liver and Age-Related Liver Disease. Front Immunol. 2018;9:2795.

11. Kim EJ, Kim HJ. Nonalcoholic fatty liver disease in obese and nonobese pediatric patients. Korean J Pediatr. 2019;62:30-35.

12. Carr RM, Oranu A, Khungar V. Nonalcoholic Fatty Liver Disease: Pathophysiology and Management. Gastroenterol Clin North Am. 2016;45:639-652.

13. He W, An X, Li L, et al. Relationship between Hypothyroidism and NonAlcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis. Front Endocrinol (Lausanne). 2017;8:335.

14. Mantovani A, Nascimbeni F, Lonardo A, et al. Association Between Primary Hypothyroidism and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. Thyroid. 2018;28:1270-84.

15. Jaruvongvanich V, Sanguankeo A, Upala S. Nonalcoholic Fatty Liver Disease Is Not Associated with Thyroid Hormone Levels and Hypothyroidism: A Systematic Review and Meta-Analysis. Eur Thyroid J. 2017;6:208-15.

16. Viglino D, Jullian-Desayes I, Minoves M, et al. Nonalcoholic fatty liver disease in chronic obstructive pulmonary disease. Eur Respir J. 2017;49:1601923.

17. Moon SW, Kim SY, Jung JY, et al. Relationship between obstructive lung disease and non-alcoholic fatty liver disease in the Korean population: Korea National Health and Nutrition Examination Survey, 2007-2010. Int J Chron Obstruct Pulmon Dis. 2018;13:2603-11.

18. Petrović G, Bjelaković G, Benedeto-Stojanov D, et al. Obesity and metabolic syndrome as risk factors for the development of non-alcoholic fatty liver disease as diagnosed by ultrasound. Vojnosanit Pregl. 2016;73:910-20.